The question facing healthcare leaders today is no longer whether Artificial Intelligence (AI) will be transformative, but whether our organizations can transform quickly enough to harness it at an enterprise
Researchers Say Whole-Body MRI Companies Are Inflating the Scans’ Medical Benefits
A growing number of Americans are paying thousands of dollars out of pocket for elective whole-body MRI scans, drawn by the promise of catching fatal diseases early. The companies offering
Kardigan’s IPO Lands $400M for Drugs That Get to Root Causes of Heart Diseases
Cardiovascular disease drugs continue to rank among the most prescribed medicines, but there’s still leave plenty of unmet medical need. Many of these products are one-size-fits all and they manage
Lantern, Marathon Health Launch Partnership to Provide Integrated Primary and Specialty Care
Specialty care company Lantern and primary care provider Marathon Health introduced a new partnership on Thursday that aims to bring down specialty care spend for employers. Dallas, Texas-based Lantern directs
What Life Sciences Companies Get Wrong When Building Cross-Border R&D Structures
Cross-border structures in life sciences are no longer the exception; they are the rule. Whether it’s an Israeli biotech starting up a U.S. subsidiary to tap into the talent pipeline
What Is AI Getting Right — and Wrong — in Healthcare’s Revenue Cycle?
Two to three years ago, investors were telling startups that clinical coding would be fully automated by LLMs within a year — which didn’t quite turn out to be true.
KFF: Insurer Participation in ACA Marketplaces Is Down
A new analysis from KFF shows that for the first time since the enhanced premium tax credits were introduced in 2021, insurer participation in the Affordable Care Act Marketplaces has
Combined GI Procedures Are Becoming Routine – AI Can Help Address the Gap in Upper GI Quality Standards
Most patients who undergo a combined upper and lower GI endoscopy think of it as one procedure. In clinical terms, it is two: an esophagogastroduodenoscopy examining the upper tract, followed
New Cancer Biotech Unveils $27M for Dual-Targeting Prostate Cancer Drug
Prostate cancer can be treated with targeted therapies, but there are still opportunities to improve on this approach. MultiValent Biotherapies is going after two validated cancer targets with a single
InStride Raises $30M to Scale Pediatric Mental Health Support
InStride Health, a pediatric mental health provider, announced Monday that it raised $30 million in Series C funding to expand into new markets. Boston-based InStride Health provides virtual specialty outpatient









